FDA Inspection 1040787 — Amrex Zetron Inc

Amrex Zetron Inc — FEI 2011115

The FDA completed an inspection of Amrex Zetron Inc on January 17, 2018 in Paramount, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 17, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Paramount, CA (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
334721 CFR 820.200(c)Service reports/MDRs/complaints
341521 CFR 820.22Quality Audit/Reaudit - conducted